EF Hutton Reiterates Buy on Jasper Therapeutics, Maintains $6.85 Price Target

EF Hutton analyst Michael King reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Buy and maintains $6.85 price target.

EF Hutton analyst Michael King reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Buy and maintains $6.85 price target.

Total
0
Shares
Related Posts